Briumvi (ublituximab) has been approved by NICE (National Institute for Health and Care Excellence) for people with active relapsing remitting multiple sclerosis. In England and Wales, NICE has ...

Brain Cancer Canada is excited to announce a $50,000 grant awarded to Dr. Shawn Beug, Scientist at the Children's Hospital of Eastern Ontario Research Institute, and his team. The project aims to ...

When conflict becomes a recurring pattern, it shifts from occasional stress to chronic strain on the body. The stress builds ...

Rising blood levels of an inflammatory marker, neutrophil-to-lymphocyte ratio, linked to poorer outcomes with chronic kidney ...

Interleukin-2 (IL-2) is a well-known cytokine that plays a crucial role in stimulating immune cells, including natural killer (NK) cells and cytotoxic T cells. It has been studied as an immunotherapy ...

Johnson & Johnson today announced new frontline data featuring TECVAYLI® (teclistamab-cqyv) from two investigational studies in patients with newly diagnosed multiple myeloma (NDMM) in induction and ...

Renowned Zimbabwean singer Admire Sanyanga Sibanda, popularly known as Chief Hwenje, is on the path to recovery after ...

The results of two important lymphoma studies led by experts at Roswell Park will be presented during oral abstract sessions this morning at the 66th annual meeting of the American Society of ...

Medically reviewed by Doru Paul, MD Leukemia is a cancer that changes blood cells. It usually develops in the bone marrow, the inner part of the bone that makes immature cells that eventually develop ...

SPANISH scientists have found a remarkably simple treatment for cancer- aspirin.  Young Spanish scientists have discovered a ...

A new study shows which blood-based sarcopenia indicators can predict mortality in people with Alzheimer’s disease.